Search

everythinglearnresearchcommunity

for

Search:↓

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Obesity worsens skin health and losing weight can improve skin conditions.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Skin diseases alter the skin's microbiome, and prebiotic treatments might help.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Most Spanish Caucasian women have a widow's peak, and their hormone levels suggest they process certain hormones faster.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Acne-affected skin has more inflammation-related proteins and bacteria than healthy skin.